Customize
Quick Links
Past Events

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Disclaimer

Not an official event of the 2017 ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the Conquer Cancer Foundation.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Eisai Inc. and Exelixis, Inc.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2017
Physicians’ Education Resource ®, LLC.
All rights reserved.

Show Me the Data: The Experts Weigh-In on Evidence to Support Strategies for Classic Clinical Scenarios in Renal Cell Carcinoma

Show Me the Data: The Experts Weigh-In on Evidence to Support Strategies for Classic Clinical Scenarios in Renal Cell Carcinoma


Friday, June 2, 2017
7:00 PM - 9:00PM
Dinner and registration: 6:30PM - 7:00PM

Hilton Chicago
International Ballroom North (Lobby Level)

720 S Michigan Avenue
Chicago, IL 60605

Overview:

The landscape of renal cell carcinoma (RCC) management has changed dramatically in recent years with the approval of new agents. The availability of these agents, along with data updates on their efficacy and safety, has complicated RCC treatment planning in terms of therapeutic selection and sequencing, toxicity management, and dose/schedule optimization. Additionally, positive results from studies of novel single-agent and combination therapies, biomarkers, and approved agents in new lines of therapy suggest more changes are on the horizon in RCC management. To help clinicians in their day-to-day practices, this case-based satellite symposium will broach a variety of clinical scenarios at key junctures in care, with the understanding that real-world scenarios cannot always be bucketed neatly into simple “lines of therapy.” The format of this activity will provide the audience with an opportunity to interact with the expert faculty panel and to reflect on how they arrive at the decisions they make, how their decisions compare with those of the faculty, whether they have a deep understanding of landmark trial results, and how to better contextualize evidence to optimize decision making at key decision points along the RCC treatment continuum.

Target Audience:

This educational program is directed toward medical oncologists, surgical oncologists, and radiation oncologists interested in the treatment of RCC. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with RCC will be invited to participate.

Learning Objectives:

Upon completion of this activity, participants will be able to:

  1. Substantiate their treatment decisions in the management of advanced RCC at key decision points along the disease continuum based on the most relevant clinical trial evidence
  2. Integrate knowledge of single-agent and combination strategies in the context of mechanisms of action, kinetics of response, best practices in monitoring, and key information that informs switching decisions in the care of patients with advanced RCC
  3. Manage treatment-related toxicities and practically apply knowledge of adverse events as a component of monitoring and therapeutic decision making in RCC treatment settings
  4. Assess recent clinical trial results, key ongoing trials that are highly anticipated in the field, and how emerging strategies may further impact the RCC treatment landscape


Program Chair

Toni K. Choueiri, MD
Director, Lank Center for Genitourinary Oncology
Director, Kidney Cancer Center
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Boston, MA







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
31
Filter By